|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||37.18 - 38.64|
|52 Week Range||34.60 - 65.30|
|Beta (3Y Monthly)||1.46|
|PE Ratio (TTM)||6.50|
|Forward Dividend & Yield||2.15 (5.36%)|
|1y Target Est||N/A|
If you own shares in Imerys SA (EPA:NK) then it's worth thinking about how it contributes to the volatility of your...
Is Imerys SA (EPA:NK) a good dividend stock? How would you know? Dividend paying companies with growing earnings can...
Every investor in Imerys SA (EPA:NK) should be aware of the most powerful shareholder groups. Generally speaking, as a company grows, institutions will increase their ownership. Conversely, insiders often decrease their ownership o...
When Iliad entered the French market with its low-cost offering, it prompted the crippling price wars which are now weighing on all those firms’ profits. A reversal of that trend could help offset the pain of lost customers. It seems likely that those funds will be used to boost the company’s presence in Italy, where growth is faster than in France.
PARIS (Reuters) - Shares in French telecoms group Iliad fell on Tuesday, as concerns over its weak results overshadowed possible plans to sell part of Iliad's mobile assets. Iliad shares were down 3.7 ...
A California jury on Wednesday awarded $29 million to a woman who said that asbestos in Johnson & Johnson's talcum-powder-based products caused her cancer. The verdict, in California Superior Court in Oakland, marks the latest defeat for the healthcare conglomerate facing more than 13,000 talc-related lawsuits nationwide. J&J said it would appeal, citing "serious procedural and evidentiary errors" in the course of the trial, saying lawyers for the woman had fundamentally failed to show its baby powder contains asbestos.
Imerys Talc America, the U.S. unit of French group Imerys SA, said it filed for bankruptcy because it lacks the financial clout to defend against nearly 15,000 lawsuits over its talc mineral product, which is also used in cosmetics. Imerys said that while it continued to believe the lawsuits are without merit, the prospect of rising settlement and defense costs over the next few years prompted the decision to file for bankruptcy. In July, a Missouri jury ordered J&J to pay a record $4.69 billion (3.65 billion pounds) to 22 women who said asbestos in talc caused ovarian cancer.
Imerys Talc America Inc, a supplier to healthcare conglomerate Johnson and Johnson Inc , said in a statement on Wednesday it was filing for Chapter 11 bankruptcy protection along with two subsidiaries. ...
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Today we are going to look at Read More...
The Missouri Supreme Court on Thursday halted an upcoming trial in a case brought by women who claim talc supplied by Imerys Talc America for use in Johnson & Johnson products gave them cancer, saying it wanted to consider a jurisdictional challenge by Imerys. It is the second major talc case the Missouri high court has stayed in recent weeks on jurisdictional grounds. Both were in the St. Louis' 22nd Circuit Court, which has issued several large verdicts against J&J and Imerys, including one for $4.7 billion in July.
This article is written for those who want to get better at using price to earnings ratios (P/E ratios). We'll show how you can use Imerys SA's (EPA:NK) P/E ratio Read More...
The lawsuit brought by Terry Leavitt in Alameda Superior Court in Oakland is the first of over a dozen J&J talc cases scheduled for trial in 2019. The company is facing some 11,700 lawsuits over the safety of talc in its products. Leavitt's lawyer, Joseph Satterley, accused J&J in his opening statement of knowingly selling a dangerous product, according to an online broadcast by Courtroom View Network.